Award
National Cancer Institute 5R35CA210087-09
Human natural killer cells: Advancing biology and clinical applications
Recipient
Beckman Research Institute/City of Hope, Duarte, CA, United States
Award Amount
$886,438.00
Ceiling
$886,438.00
Awarded
July 28, 2026
Identifier
5R35CA210087-09
The award funds research to improve NK cell-based therapies for cancer by addressing NK cell exhaustion, memory, trafficking, and clinical translation, including CAR NK cells for pancreatic cancer.
Description
This NIH grant supports research on engineered natural killer (NK) cells, including CAR NK cells, for cancer therapy, with a focus on overcoming exhaustion, understanding memory, improving trafficking, and translating findings into clinical applications for pancreatic and other cancers.